Introduction
Brefeldin A (BFA) is a fungal metabolite with a unique ability to disrupt the secretory apparatus of cells (reviewed in 8.17). After initial observations that BFA prevented the export of newly synthesized proteins from the endoplasmic reticulum (ER) (12, 19) , it was found that BFA induces the disappearance of the Golgi complex (6) and the retrograde transport of Golgi complex resident and itinerant proteins to the ER (4,lO). Subsequently, it was shown that BFA also affects the morphology and, incompletely, the function of the endosomal compartment (3, 7, 11, 21) . The initial effect of BFA on the Golgi complex is the rapid dissociation of peripheral membrane proteins from the cytosolic surface of the Golgi complex ( 5 ) . The same proteins are not released from the Golgi complex of certain cells resistant to the effects of BFA (9) . These findings suggest that dissociation of proteins from the cytosolic surface of the Golgi complex membrane is responsible for the action of BFA on the Golgi complex. The remarkable effects of BFA on secretory organelles have led to an intense search for its cellular target. BODIPY and BM. Therefore, BODIPY-BE4 is probably inactive until BFA is released by cellular esterases. The specific localization of BODIPY-BFA to the ER and Golgi complex suggests that BE4 might exert its effects on vesicular t d i d ting by perturbing the lipid bilayer of its target organelles. Because BODIPY-BE4 intensely stains the ER at concentrations that have no discernible effects on intracellular transport or other cellular functions, it should be useful for visualizing the ER in living cells. ( J Histochem Cyrdem
43907-915, 1995)
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To better understand the mechanisms of BFA action on the secretory pathway, we conjugated BFA to fluorophore boron dipyrromethene difluoride (BODIPY). We describe here the biological activity of these conjugates and their staining of living cells.
Materials and Methods
Materials. Chemically synthesized brefeldin A purchased from Dr. E.C. Corey (Harvard University, Cambridge, MA) was used as the substrate for the synthesis of fluorescent BFA conjugates. BODIPY I and BODIPY I1 are commercially available from Molecular Probes (Eugene, OR). The mouse MAb M3A5, specific for B-COP (1) . was provided by Dr. Thomas Kreis (EMBL; Heidelberg, Germany). AMCA-conjugated donkey anti-mouse IgG or anti-rabbit IgG antibodies were obtained from Jackson ImmunoResearch (West Grove, PA). Lucifer Yellow, DiOC6, and NBD-ceramide were obtained from Molecular Probes. cells. L929, CV1, MRC-5, and Ptk2 cell lines were obtained from American Type Culture Collection (Rockville, MD). Cells were cultured at 37'C in 91%/9% air/COz in Dulbecco's minimum essential medium (DMEM) supplemented with 7.5% FBS. For immunofluorescent staining or other light microscopy observation, cells were cultured for 18 hr on 12-mm diameter number 0 covenlips that had been acid-cleaned and stored in ethanol. 
and BODIPY FL (3-4,4-difluro-5,7-dimethyl-4-bora-3a,4a-di~a-s-indacen-
3-y1)propionic acid) and the mixture was stirred at ambient temperature for 18 hr. The products were concentrated under vacuum and purified by preparative thin layer chromatography (silica gel 60 F254.0.5 mm; elution with 0.5% methanol in chloroform). The two desired bands were separated and extracted with chloroform to yield 1.4 mg of gBFA I (Rf = 0.43, 5% methanol in chloroform) and 0.5 mg gBFA I1 (Rf = 0.33, 5% methanol in chloroform). The absorption and emission maxima of the compounds in methanol are 503 nm and 512 nm. respectively. Another BFA conjugate was made similarly by reacting 5 mg of BFA with 6 mg BODIPY 558/568 (3-4,4-difluro-5-(2-thienyl)-4-bora-~a,4a-diaza-s-indacen-3-yl)propionic acid). One of the reaction products was 1.4 mg rBFA (Rf = 0.35, 10% methanol in chloroform), with absorption and emission maxima in methanol of 558 nm and 568 nm, respectively. The structures of the BFA conjugates shown in Figure 1 was confirmed by 3H NMR spectroscopy.
Purifation and Quantitation of BFA and BODIPY-BFA Conjugates. BFA and BFA conjugates were purified and analyzed by HPLC using a Waters 3.9 x 30-cm C18 column consisting of 15-pm particles with 300-A pores. Samples were loaded in 5 mM triethyammonium-phosphate buffer and eluted at 1 mllmin with a gradient of 0-100% of acetonitrile. Under these conditions, BFA eluted at 13 min, BODIPY at 15 min, rBFA at 20 min. and gBFA I and I1 at 25 min. For purification, 1-ml fractions were collected, and fractions containing BODIPY-BFA conjugates were dried under vacuum, re-suspended in ethanol, and used as stock solutions. Concentrations of BFA and conjugates were calculated from spectrophotometry using the fol-Vital Staining Cells. Number 0 acid-cleaned glass coverslips on which cells were cultured for 18 hr were mounted on a chamber produced by adhering to an ethanol-cleaned glass microscope slide a piece of silicon rubber with holes made with a cork borer as described by Terasaki (20) . The chamber was filled with culture medium containing fluorescent dyes. For double labeling of cells with rBFA and DiOC6, cell chambers were filled with culture medium containing 0.2 pglml rBFA and 0.5 pglml DiOc6 and the staining patterns were examined by epifluorescence microscopy. Staining with individual dyes demonstrated that the filter sets used exclusively allowed visualization of the appropriate dye. To double label cells with rBFA and Lucifer yellow, cells on coverslips were cultured in medium with 0.5 mglml Lucifer yellow for 18 hr. Cells were washed three times with dye-free medium. Coverslips were then transferred to the cell chamber filled with culture medium containing 0.2 pglml of rBFA. gBFA and rBFA can be visualized, respectively, with standard filter sets used for fluorescein and rhodamine.
Immunofluorescence Staining. Cells grown on cleaned glass coverslips were washed three times with DPBS and faed by incubation with 3% (wlv) paraformaldehyde in DPBS for 10 min at room temperature (RT). After three washes with DPBS, cells were co-incubated for 30 min at RT with the first antibody diluted in DPBS with 1% (wlv) BSA and 0.1% (wlv) saponin. Cells were washed three times with DPBS and co-incubated with AMCAconjugated anti-IgG antibodies diluted 1:100 in DPBS with 1% BSA and 0.1% saponin. After 30-min incubation at 37'C, cells were washed three times with DPBS and then mounted on glass slides using Mowiol-glycerol supplemented with 5% (wlv) diazo-bicyclo-octane to retard fading. Slides were incubated overnight to allow hardening of the mountant. For localization of p-COP, cells were fixed in methanol at -2O'C for 10 min and then further permeabilized with acetone at -20°C for 1 min, since b-COP antigenicity is destroyed by aldehyde fixation. For cell surface staining of the influenza virus hemagglutinin (HA), cells grown on coverslips were infected with influenza virus AlPuerto Rico/8/34 (HlNl) as described (18) . Cells were washed twice with DPBS and incubated with different conccntration of BFA. gBFA, or rBFA for 4 hr before fucation with paraformaldehyde.
Microscopy and Image Analysis. Fluorescent compounds were located in cells either by conventional epifluoresccnce using a Zeiss Axiphot with a mercury arc lamp or a Zeiss Axioplan equipped with a BioRad MRC 600 laser scanning confocal microscope (LCSM) system that utilizes a mixed krypton-argon laser. Specimens were viewed with a x 63 1.4 NA planapochromat Objective. with the exception of AMCA-stained cells, since this objective is not suitable for excitation with w light. In this case. a x 100 1.3 NA neofluor objective was used. were incubated with 0.5 ml of medium with 20 mM of BODIPY-BFA at 37°C with gentle rotation for 15-120 min. after which cells were centrifuged and the medium collected. Cell pellets were extracted with 1% Triton X-100. Both the medium and detergent extract were vacuum-dried and samples were re-suspended in 100 pI 50% acetonitrile 50% 5 mM phosphate buffer. Suspensions were filtered and analyzed by HPLC as described above.
Results
To study the localization of BFA in cultured cells, three BODIPY conjugates were produced ( Figure 1 ). Two of the conjugates consisted of BODIPY I (green fluorescence) coupled to one of the available hydroxy groups. These compounds behaved almost identically in the experiments to be described below, and only results with one of the compounds (gBFA I) are shown. The other conjugate (rBFA) consisted of BODIPY I1 (red fluorescence) conjugated to the same hydroxy group as gBFA I. As described below, gBFA I and rBFA differed somewhat in their biological activities but stained cells in a highly similar manner.
When living cells were incubated with culture medium containing fluorescent BFA conjugates and examined by standard epifluorescence, the anastomosing network of the ER was easily observed in the periphery of CV-1 cells (Figure 2 ). In the central part of the cell, the network became more dense, and although the nucleoplasm was spared, the nuclear membrane (which is contigu-ous with the ER) was intensely stained. Similar patterns were obtained after staining of the three cell lines examined: L929 (mouse), CV-1 (monkey), MRC-5 (human) (not shown), and PtK2 (kangaroo rat) (Figure 3) .
The staining of the ER by conjugated BFA was further confirmed using an LCSM to produce serial sections of stained PtK2 cells. This most clearly revealed the architectural relationship of the ER to the cell (Figure 3) . Computer reconstruction of the sections provided a unique three-dimensional rendering of the ER in which the entire nuclear membrane is clearly stained by gBFA I.
The intracellular staining shown in Figures 2 and 3 is conferred by BFA, since unconjugated BODIPY did not accumulate in cell membranes. Membrane staining by the BODIPY-BFA conjugates cannot be attributed solely to modification of the polar carboxylic group with a hydrophobic ring, because BODIPY esterified to cyclopentanol did not stain intracellular membranes when used at the same concentrations (not shown).
To determine the extent to which BFA conjugates stained other organelles in addition to the ER, viable L929 cells were double stained with rBFA and dyes that stain mitrochondria, the Golgi complex, or lysosomes. To locate mitochondria, DiOQ was used at low concentrations [at high concentrations D i O G has been used extensively as a vital marker for the ER (19) and, indeed, the ER staining with rBFA co-localized with DIOQ used at high concentration (not shown)]. As shown in Figure 4C , conventional fluorescence microscopy revealed that DiOC6 brightly stained the mitochondria, with little staining of the ER. By contrast, rBFA predominantly stained the ER ( Figure 4A ), although weak staining of some mitochondria was also observed when the intensity of lower staining areas was enhanced using computer Software (Figure  4 B two mitochondria stained by rBFA are indicated by arrows).
The possible localization of rBFA to the Golgi complex was examined by simultaneously staining PtK2 cells with NBD-ceramide under conditions in which NBD-ceramide selectively labeled the Golgi complex (15.16 ). Using the LCSM, the Golgi complex was easily identified by NBD-ceramide as a characteristic ribbon-like structure in a juxtanuclear position ( Figure 5C ). This structure was also stained by rBFA, although the staining was difficult to discern above the intense ER staining ( Figure SA) . By using computer software to adjust the black level of the image, it could be appreciated that rBFA co-localized with the NBD-ceramide ( Figure 5B ).
In addition to staining the ER and Golgi complex, rBFA was also localized in small filled structures scattered in the cytoplasm (5-5O/cell). The size of these structures was similar to that of lysosomes, although their relatively low abundance indicated that they represented only a subset of lysosomes, which are present in cells in roughly 10-fold higher numbers. To identlfy endosomes and lysosomes, L929 cells were cultured for 18 hr at 37°C with medium supplemented with the fluid phase marker Lucifer yellow and, after washing, mounted in culture medium containing rBFA. As seen in Figure 6 , Lucifer yellow-positive vesicles and rBFA-positive vesi- (B) The intensity of low-value pixels in A was increased to demonstrate the weak staining of mitochondria by rBFA. Although we did not detect co-localization of stains with all mitochondria. some were clearly stained by rBFA (arrows). Bar = 10 pm. cles were largely unrelated, with very few of the many vesicles demonstrating spatial overlap. This indicates that BFA is not selectively incorporated into the lumen or membrane of endosomes or lysosomes.
On the basis of these findings, we concluded that BFA targets BODIPY to the ER and Golgi complex of living cells (and a small dispersed structure of unknown nature), whereas lower concentrations accumulate in mitochondria and subdetectable levels are present in endosomes, lysosomes, and the plasma membrane.
BFA binds rapidly to intracellular membranes. Immediately after addition of BODIPY-BFA to cells the ER is clearly stained, even in the continued presence of the dye. Although the BODIPY-BFA conjugates could be visualized in the ER in the presence of the conjugate, the visualization of intracellular membranes was en- hanced by washing cells free of the unbound conjugate before observation. ER staining could be observed when gBFA I or rBFA was added at concentrations as low as 0.35 nM. The staining of intracellular membranes by BODIPY-BFA occurred with both aldehydefixed and viable cells and was not affected in either situation by lowering the temperature to 4°C (not shown), but was completely abrogated when lipids were extracted from fixed cells by brief exposure to 1% Triton X-100.
To quantitate the binding and dissociation of BODIPY and BODIPY-BFA from membranes, cells were incubated with BODIPY, gBFA I, or rBFA for 10 min, rapidly washed, and then detergentextracted after different periods of time of incubation in DPBS at 37°C. The amount of dye extracted by detergent was then measured fluorometrically. This revealed that gBFA I bound to cells 15to 20-fold better than unconjugated BODIPY, and dissociated from cells with a half-time of approximately 30 min. It was not possible to block the binding of gBFA I to cells with even 100-fold greater amounts of unconjugated BFA. These findings strongly suggest that BODIPY-BFA staining of intracellular membranes is due to its interactions with lipids. The selective staining of the ER and Golgi complex most likely results from differences in lipid composition between the ER and Golgi complex and other cellular membranes.
The biological activities of the BODIPY-BFA conjugates were initially determined by examining their effects on the intracellular trafficking of the influenza virus hemagglutinin in virus-infected cells, as measured by immunofluorescence detection of HA on the cell surface and oligosaccharide modification of [3'S]-methioninelabeled HA. These experiments revealed that gBFA and rBFA were biologically active, but only at 5-and 20-fold higher concentrations, respectively, than unconjugated BFA (not shown). We next examined the ability of the BODIPY-BFA conjugates to disperse P-COP from the Golgi complex to the cytosol, which is the first detectable effect of BFA on cells. As previously reported, @COP dispersal occurred as early as 30 sec after addition of BFA at 20 BM. By contrast, @COP dispersal required 30 min after the addition of gBFA I at the same concentration. Incubation of cells with 20 WM rBFA for 30 min did not affect P C O P distribution (not shown).
One explanation for the decreased efficiency of BFA conjugates on exocytosis and the delay in releasing P-COP from the Golgi complex is that the conjugates themselves are inactive but are cleaved by cellular esterases to release unconjugated BFA. To test this, L929 cells were incubated with 20 pM gBFA I for increasing times at 37'C. pelleted, and media and cell lysates collected and analyzed by HPLC under conditions that clearly separate BFA. BODIPY, and gBFA I (Figure 7) . Incubation of gBFA I with growth medium had no effect on its HPLC profile, indicating a minimal level of serum es- terases capable of hydrolyzing gBFA I. However, when gBFA I was incubated with cells, gBFA I was metabolized into a species coeluting with free BODIPY. The ratio of free to conjugated BODIPY was similar in cells and the medium. The rate of BODIPY-BFA hydrolysis was proportional to the amount of cells added (not shown). The rate of hydrolysis is approximately 10' molecules/celllmin. Using this figure, we would expect that the concentration of BFA released from gBFA I would reach 1 pM after 3-min incubation in the p-COP dispersion assay (approximately lo5 cells incubated in 50 ml of medium), which should be sufficient to account for the observed effect (5). These findings strongly suggest that the biological activity of BODIPY-BFA conjugates depends on their conversion to free BFA. which accounts for their diminished dficiency and their delayed action.
Discussion
The most important question raised by the present study is whether the localization of BODIPY-BFA to the ER and Golgi complex is related to the biological activity of BFA. We cannot answer this question with any certainty. The conjugates clearly stained both the ER and Golgi complex of PtK2 cells, which are resistant to the effect of BFA on the Golgi complex. Therefore, the localization of BODIPY-BFA to the ER and Golgi complex does not simply correlate with the ability of BFA to modlfy the structure and function of the Golgi complex. Moreover, our findings suggest that the conjugates themselves have little intrinsic biological activity. This finding is consistent with prior observations that the biological ac-tivity of BFA is destroyed by minor modifications of the atoms via which BODIPY was esterified to BFA (14) . The biological inactivity of the BODIPY-BFA conjugates does not, however, necessarily mean that they retain no functional relationship to BFA. Our findings suggest that BFA is selectively incorporated into ER and Golgi complex membranes on the basis of its interaction with lipids present in these bilayers. The biological activity of BFA may require both localization in inuaceilular membranes and perturbation of the membrane (or a membraneassociated protein). The addition of BODIPY might preserve the localization of BFA to target membranes but interfire with its ability to properly perturb membranes or membrane-associated proteins. This perturbation might be the formation of ion channels, since BFA has been reported to produce cation channels in artificial lipid bilayers (22) . Alternatively, BFA might act directly to disfavor the association of peripheral membrane proteins necessary to the structural integrity of the Golgi complex. The idea that BFA acts by perturbing membrane structure is consistent with a recent report (13) that the resistance of some cells to BFA can be partially reversed simply by the addition of C6-ceramide, which is known to accumulate in the Golgi complex (16). Moreover, the failure to detect the stable interaction of BFA with proteins involved in vesicular &icking (2) . is consistent with this idea, as is the ability of BFA to alter vesicular trafficking in a wide variety of eukaryotic cells. including yeast, plant, and vertebrate cells.
Regardless of their relationship to BFA, the BODIPY-BFA conjugates described here represent unique probes for studying the ER in living cells. They o f & a major advantage over DiOG, which is presently used for this purpose, inasmuch as they label the ER gBFA 8z Cells at concentrations that have little effects on cell physiology, whereas DiOG must be used at concentrations toxic to mitochondria which are selectively stained by dye (20) . One problem associated with BODIPY-BFA labeling of the ER is staining of the Golgi complex. Because the Golgi complex is almost always located in a juxtanuclear position, it will often be possible to avoid this problem in adherent cells by limiting examination to the more peripheral areas of the cell. Moreover, as we have shown here, rBFA does not interfere with the ability of NBD-ceramide to stain the Golgi complex. Using these stains in conjunction, it will be possible to simultaneously and unambiguously examine dynamic aspects of the Golgi complex and ER in healthy viable cells under various conditions.
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